Definitive Contract HHSD200201588229C
Award Date
9/28/15
Potential Completion Date
9/28/16
Potential Value
$718K
Federal Agency
CDC Office of Acquisition Services
Awardee
Qoolabs Inc.
Ultimate Awardee
Not listed
NAICS Category
541711 - Research and Development in Biotechnology
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Cost Plus Fixed Fee
Place of Performance
Chamblee, GA 30341, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Other Statutory Authority
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for SBIR Phase II research and development work by Qoolabs Inc., a self-certified small disadvantaged business. The $749,999 cost-plus-fixed-fee contract was awarded on September 5, 2017 by the Department of Health and Human Services Centers for Disease Control and Prevention. The work is being performed in Atlanta, Georgia and involves the development of medical technologies related to infectious diseases, immunology, and cancer detection. This includes research...
This is a firm fixed-price purchase order contract awarded by the Centers for Disease Control and Prevention (CDC) to Qoolabs Inc., a self-certified small disadvantaged and woman-owned business. The $150,000 contract is for critical functions, with a period of performance ending on March 20, 2017. Qoolabs Inc. is a biotech company that has received over $4 million in prime federal contracts from the Department of Health and Human Services (HHS), including the National Institutes of Health (NIH),...
This is a $1,500,000.00 SBIR Phase II contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services (HHS), to Qoolabs Inc., a small disadvantaged and woman-owned business located in Carlsbad, California. The contract is for research and development of medical technologies related to infectious diseases, immunology, and COVID-19 detection, including the development of affinity reagents,...
This is a $300,000 Firm Fixed Price contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Qoolabs Inc., a small disadvantaged business located in Carlsbad, California. The contract is for research and development under the Small Business Innovation Research (SBIR) program, with a period of performance through September 2025. Qoolabs is developing medical technologies related to infectious diseases, immunology,...
This $600,000 firm fixed price definitive contract was awarded by the National Institutes of Health's National Institute of Allergy and Infectious Diseases to Qoolabs Inc. of Carlsbad, California under Solicitation Number NIH-CDC-SBIR-2023 in response to Topic 118. The contractor will conduct research and development over a two year period to produce reagents for immunologic analysis of non-mammalian and underrepresented mammalian disease models, in support of the NIH and CDC's missions. This...
The Department of Health and Human Services Centers for Disease Control and Prevention awarded a Small Business Innovation Research (SBIR) Phase I contract to Qoolabs Inc., a self-certified small disadvantaged business, to conduct research on finding human carriers of taeniasis to prevent neurocysticercosis epilepsy. The $150,000 firm-fixed-price contract was awarded on September 17, 2018 with a completion date of September 16, 2019. Qoolabs Inc. has received over $4 million in prime federal...
This is a $116,371.20 firm-fixed-price purchase order contract awarded by the Department of Health and Human Services Centers for Disease Control and Prevention (CDC) to Copial Business Strategists, LLC, an 8(a) certified small disadvantaged business. The contract is for laboratory technician services in support of the CDC's National Center for Emerging and Zoonotic Infectious Diseases (NCEZID) program. Copial Business Strategists, a minority-owned and woman-owned small business, holds...
This is a Small Business Innovation Research (SBIR) Phase II contract awarded by the Centers for Disease Control and Prevention (CDC) to Microbplex Inc., a minority-owned, economically disadvantaged women-owned small business. The contract has a ceiling value of $987,059.00 and is a Cost Plus Fixed Fee definitive contract. The period of performance runs from September 28, 2015 to September 27, 2017. The contract does not have a set-aside designation. Based on the SBIR program description, this...
This is a small business set-aside contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Qoolabs Inc., a woman-owned small disadvantaged business in California. The $300,000 firm-fixed-price contract is for the development of affinity reagents for the immune system of guinea pigs. Qoolabs Inc. has previously received over $4 million in prime federal contracts from HHS agencies like NIAID and NCI for research and...
This is a $21,208,581.76 cost-plus-fixed-fee definitive contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a division of the Department of Health and Human Services (HHS), to Quality Biological Inc., a self-certified small disadvantaged business. The contract has a total small business set-aside designation and an ultimate completion date of April 7, 2025. Quality Biological Inc., through its Quality Biological, Inc. division, is a minority-owned...